Intermediate for Lesinurad. Lesinurad (trade name Zurampic) is a urate transporter (URAT1) inhibitor for treating hyperuricemia associated with gout. It received FDA approval on 22 December 2015. Lesinurad has been approved by the U.S Food and Drug Administration on 22 December 2015.
Product Name: 1-Cyclopropyl-4-isothiocyanatonaphthalene
CAS Number: 878671-95-5
Molecular Weight:  225.3076
Molecular Formula:  C14H11NS
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.